{A figure is presented}High Somatic Symptom Burdens and Functional Gastrointestinal Disorders

Clinical Gastroenterology and Hepatology

Volumn 5, Issue 5, 2007, Pages 556-562

  Sayuk, Gregory S ^a   Elwing, Jill E ^a   Lustman, Patrick J ^a,b   Clouse, Ray E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ANXIETY DISORDER; ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL STUDY; COMORBIDITY; CONTROLLED STUDY; DATA EXTRACTION; DEPRESSION; DIAGNOSTIC TEST; DIGESTIVE SYSTEM FUNCTION DISORDER; FEMALE; GASTROENTEROLOGY; GASTROINTESTINAL SYMPTOM; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTCOME ASSESSMENT; OUTPATIENT; PATIENT REFERRAL; PREDICTION; SELF REPORT; SEX DIFFERENCE; SOMATIZATION; STATISTICAL ANALYSIS; COST OF ILLNESS; GASTROINTESTINAL DISEASE; MIDDLE AGED; PREDICTION AND FORECASTING; PSYCHOLOGICAL ASPECT; RETROSPECTIVE STUDY; SOMATOFORM DISORDER; STATISTICAL MODEL;

ADULT; ANXIETY DISORDERS; COST OF ILLNESS; DEPRESSIVE DISORDER; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SOMATOFORM DISORDERS;

EID: 34247534139     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2006.11.024     Document Type: Article

References (68)

1. North C.S., Downs D., Clouse R.E., et al. The presentation of irritable bowel syndrome in the context of somatization disorder. Clin Gastroenterol Hepatol 2 (2004) 787-795
2. Clouse R.E., and Lustman P.J. Use of psychopharmacological agents for functional gastrointestinal disorders. Gut 54 (2005) 1332-1341
3. Kirmayer L.J., and Robbins J.M. Three forms of somatization in primary care: prevalence, co-occurrence, and sociodemographic characteristics. J Nerv Ment Dis 179 (1991) 647-655
4. Simon G.E., and Von Korff M. Somatization and psychiatric disorder in the NIMH Epidemiologic Catchment Area study. Am J Psychiatry 148 (1991) 1494-1500
5. Lipowski Z.J. Somatization: the experience and communication of psychological distress as somatic symptoms. Psychother Psychosom 47 (1987) 160-167
6. Kellner R. Somatization: theories and research. J Nerv Ment Dis 178 (1990) 150-160
7. Katon W., Lin E., Von Korff M., et al. Somatization: a spectrum of severity. Am J Psychiatry 148 (1991) 34-40
8. Diagnostic and statistical manual of mental disorders. 4th rev ed. (2000), American Psychiatric Association, Washington, DC
9. Brown W.H., Chey W.D., and Elta G.H. Number of responses on a review of systems questionnaire predicts the diagnosis of functional gastrointestinal disorders. J Clin Gastroenterol 36 (2003) 222-227
10. Wise J.L., Locke G.R., Zinsmeister A.R., et al. Risk factors for non-cardiac chest pain in the community. Aliment Pharmacol Ther 22 (2005) 1023-1031
11. Whitehead W.E., Palsson O., and Jones K.R. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?. Gastroenterology 122 (2002) 1140-1156
12. Locke III G.R., Zinsmeister A.R., Fett S.L., et al. Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil 17 (2005) 29-34
13. Schwarz S.P., Blanchard E.B., Berreman C.F., et al. Psychological aspects of irritable bowel syndrome: comparisons with inflammatory bowel disease and nonpatient controls. Behav Res Ther 31 (1993) 297-304
14. Clouse R.E., and Alpers D.H. The relationship of psychiatric disorder to gastrointestinal illness. Annu Rev Med 37 (1986) 283-295
15. Miller A.R., North C.S., Clouse R.E., et al. The association of irritable bowel syndrome and somatization disorder. Ann Clin Psychiatry 13 (2001) 25-30
16. Walker E.A., Roy-Byrne P.P., Katon W.J., et al. Psychiatric illness and irritable bowel syndrome: a comparison with inflammatory bowel disease. Am J Psychiatry 147 (1990) 1656-1661
17. Masand P.S., Kaplan D.S., Gupta S., et al. Major depression and irritable bowel syndrome: is there a relationship?. J Clin Psychiatry 56 (1995) 363-367
18. Blanchard E.B., Scharff L., Schwarz S.P., et al. The role of anxiety and depression in the irritable bowel syndrome. Behav Res Ther 28 (1990) 401-405
19. Jackson J.L., O'Malley P.G., Tomkins G., et al. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 108 (2000) 65-72
20. Drossman D.A., Toner B.B., Whitehead W.E., et al. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology 125 (2003) 19-31
21. Clouse R.E., Lustman P.J., Eckert T.C., et al. Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities: a double-blind, placebo-controlled trial. Gastroenterology 92 (1987) 1027-1036
22. Drossman D., Thompson W., Whitehead W., et al. Rome II: functional gastrointestinal disorders (2000), Degnon Assoc, Inc, McLean, VA
23. Kroenke K., Spitzer R.L., and Williams J.B. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 64 (2002) 258-266
24. Sayuk G.S., Elwing J.E., Lustman P.J., et al. Predictors of premature antidepressant discontinuation in functional gastrointestinal disorders (FGIDs): a survival analysis approach. Gastroenterology 130 Suppl 2 (2006) A-26
25. Lydiard R.B., Fossey M.D., Marsh W., et al. Prevalence of psychiatric disorders in patients with irritable bowel syndrome. Psychosomatics 34 (1993) 229-234
26. Sperber A.D., Carmel S., Atzmon Y., et al. Use of the Functional Bowel Disorder Severity Index (FBDSI) in a study of patients with the irritable bowel syndrome and fibromyalgia. Am J Gastroenterol 95 (2000) 995-998
27. Sperber A.D., Atzmon Y., Neumann L., et al. Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications. Am J Gastroenterol 94 (1999) 3541-3546
28. Barton A., Pal B., Whorwell P.J., et al. Increased prevalence of sicca complex and fibromyalgia in patients with irritable bowel syndrome. Am J Gastroenterol 94 (1999) 1898-1901
29. Veale D., Kavanagh G., Fielding J.F., et al. Primary fibromyalgia and the irritable bowel syndrome: different expressions of a common pathogenetic process. Br J Rheumatol 30 (1991) 220-222
30. Jones K.R., Palsoon O.S., Levy R.L., et al. Comorbid conditions in patients with irritable bowel syndrome: Data from a national IBS awareness registry. Gastroenterology 120 Suppl 1 (2001) A66
31. Maxton D.G., Morris J., and Whorwell P.J. More accurate diagnosis of irritable bowel syndrome by the use of "non-colonic" symptomatology. Gut 32 (1991) 784-786
32. Whorwell P.J., McCallum M., Creed F.H., et al. Non-colonic features of irritable bowel syndrome. Gut 27 (1986) 37-40
33. Liss J.L., Alpers D., and Woodruff Jr. R.A. The irritable colon syndrome and psychiatric illness. Dis Nerv Syst 34 (1973) 151-157
34. Longstreth G.F., and Wolde-Tsadik G. Irritable bowel-type symptoms in HMO examinees: prevalence, demographics, and clinical correlates. Dig Dis Sci 38 (1993) 1581-1589
35. Markowitz M., Harris W., Ricci J.-F., et al. Comorbid conditions in a patient with irritable bowel syndrome: Data from a national IBS awareness registry. Gastroenterology 120 Suppl 1 (2001) A231
36. Spiegel B.M., Kanwal F., Naliboff B., et al. The impact of somatization on the use of gastrointestinal health-care resources in patients with irritable bowel syndrome. Am J Gastroenterol 100 (2005) 2262-2273
37. Locke III G.R., Weaver A.L., Melton III L.J., et al. Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Am J Gastroenterol 99 (2004) 350-357
38. Jones M.P., and Maganti K. Symptoms, gastric function, and psychosocial factors in functional dyspepsia. J Clin Gastroenterol 38 (2004) 866-872
39. Gwee K.A., Leong Y.L., Graham C., et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 44 (1999) 400-406
40. Whitehead W.E., and Palsson O.S. Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception. Gastroenterology 115 (1998) 1263-1271
41. Rajagopalan M., Kurian G., and John J. Symptom relief with amitriptyline in the irritable bowel syndrome. J Gastroenterol Hepatol 13 (1998) 738-741
42. Lydiard R.B. Irritable bowel syndrome, anxiety, and depression: what are the links?. J Clin Psychiatry 62 Suppl 8 (2001) 38-47
43. Sharpe M., Mayou R., and Walker J. Bodily symptoms: new approaches to classification. J Psychosom Res 60 (2006) 353-356
44. Mayou R., Kirmayer L.J., Simon G., et al. Somatoform disorders: time for a new approach in DSM-V. Am J Psychiatry 162 (2005) 847-855
45. Kroenke K. Physical symptom disorder: a simpler diagnostic category for somatization-spectrum conditions. J Psychosom Res 60 (2006) 335-339
46. Walker E.A., Gelfand A.N., Gelfand M.D., et al. Psychiatric diagnoses, sexual and physical victimization, and disability in patients with irritable bowel syndrome or inflammatory bowel disease. Psychol Med 25 (1995) 1259-1267
47. Simon G.E., Von Korff M., Piccinelli M., et al. An international study of the relation between somatic symptoms and depression. N Engl J Med 341 (1999) 1329-1335
48. Lenze E.J., Miller A.R., Munir Z.B., et al. Psychiatric symptoms endorsed by somatization disorder patients in a psychiatric clinic. Ann Clin Psychiatry 11 (1999) 73-79
49. Tache Y., Martinez V., Wang L., et al. CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome. Br J Pharmacol 141 (2004) 1321-1330
50. Tache Y., Martinez V., Million M., et al. Role of corticotropin releasing factor receptor subtype 1 in stress-related functional colonic alterations: implications in irritable bowel syndrome. Eur J Surg Suppl (2002) 16-22
51. Tache Y., Martinez V., Million M., et al. Corticotropin-releasing factor and the brain-gut motor response to stress. Can J Gastroenterol 13 Suppl A (1999) A18-A25
52. Tache Y. Cyclic vomiting syndrome: the corticotropin-releasing-factor hypothesis. Dig Dis Sci 44 (1999) S79-S86
53. Posserud I., Agerforz P., Ekman R., et al. Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut 53 (2004) 1102-1108
54. Rief W., Shaw R., and Fichter M.M. Elevated levels of psychophysiological arousal and cortisol in patients with somatization syndrome. Psychosom Med 60 (1998) 198-203
55. Tillisch K., and Mayer E.A. Pain perception in irritable bowel syndrome. CNS Spectr 10 (2005) 877-882
56. Mayer E.A., Naliboff B.D., and Chang L. Evolving pathophysiological model of functional gastrointestinal disorders: implications for treatment. Eur J Surg Suppl (2002) 3-9
57. Mayer E.A., Berman S., Suyenobu B., et al. Differences in brain responses to visceral pain between patients with irritable bowel syndrome and ulcerative colitis. Pain 115 (2005) 398-409
58. Lea R., Hopkins V., Hastleton J., et al. Diagnostic criteria for irritable bowel syndrome: utility and applicability in clinical practice. Digestion 70 (2004) 210-213
59. Kroenke K., and Rosmalen J.G. Symptoms, syndromes, and the value of psychiatric diagnostics in patients who have functional somatic disorders. Med Clin North Am 90 (2006) 603-626
60. Rief W., and Hiller W. A new approach to the assessment of the treatment effects of somatoform disorders. Psychosomatics 44 (2003) 492-498
61. Kroenke K., Spitzer R.L., deGruy III F.V., et al. A symptom checklist to screen for somatoform disorders in primary care. Psychosomatics 39 (1998) 263-272
62. Swartz M., Hughes D., George L., et al. Developing a screening index for community studies of somatization disorder. J Psychiatr Res 20 (1986) 335-343
63. Othmer E., and DeSouza C. A screening test for somatization disorder (hysteria). Am J Psychiatry 142 (1985) 1146-1149
64. Escobar J.I., Rubio-Stipec M., Canino G., et al. Somatic symptom index (SSI): a new and abridged somatization construct-prevalence and epidemiological correlates in two large community samples. J Nerv Ment Dis 177 (1989) 140-146
65. Perley M.J., and Guze S.B. Hysteria: the stability and usefulness of clinical criteria-a quantitative study based on a follow-up period of six to eight years in 39 patients. N Engl J Med 266 (1962) 421-426
66. Spitzer R.L., Kroenke K., and Williams J.B. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study-Primary Care Evaluation of Mental Disorders-Patient Health Questionnaire. JAMA 282 (1999) 1737-1744
67. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), APA, Washington, DC
68. World Health Organization. The ICD-10 classification of mental and behavioral disorders (1992), WHO, Geneva